Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
6.55M
-
Shares change
-
+346K
-
Total reported value, excl. options
-
$509M
-
Value change
-
+$29.6M
-
Put/Call ratio
-
0.13
-
Number of buys
-
51
-
Number of sells
-
-34
-
Price
-
$77.74
Significant Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q4 2022
125 filings reported holding PPH - VANECK ETF TRUST - PHARMACEUTCL ETF as of Q4 2022.
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.55M shares
.
Largest 10 shareholders include Phoenix Holdings Ltd. (2.2M shares), GOLDMAN SACHS GROUP INC (1.85M shares), UBS Group AG (412K shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (344K shares), BANK OF AMERICA CORP /DE/ (298K shares), Prime Capital Investment Advisors, LLC (152K shares), MORGAN STANLEY (121K shares), LPL Financial LLC (111K shares), BNP PARIBAS ARBITRAGE, SNC (101K shares), and VALICENTI ADVISORY SERVICES INC (71.9K shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.